Barbara Krebs-Pohl
Corporate Officer/Principal bij MORPHOSYS AG
Oorsprong van het eerstegraads netwerk van Barbara Krebs-Pohl
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
61
| Public Company | Biotechnology | 61 |
Human Immunology Biosciences, Inc.
 Human Immunology Biosciences, Inc. BiotechnologyHealth Technology Human Immunology Biosciences, Inc. is a company based in South San Francisco, CA. Human Immunology Biosciences, Inc. was founded by Travis Murdoch, who has been the CEO since incorporation.
7
| Holding Company | Biotechnology | 7 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Barbara Krebs-Pohl via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| GILEAD SCIENCES, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Investor Relations Contact | |
| IMMUNOGEN, INC. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
Boehringer Ingelheim GmbH
 Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim GmbH engages in the provision of central management and other services for the group companies on behalf of C.H. Boehringer Sohn AG & Co. KG. The group specializes in the development, production, and distribution of pharmaceutical products. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
| MERCK KGAA | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| QIAGEN N.V. | Medical Specialties | Founder Public Communications Contact | |
| BAYER AG | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
Kosan Biosciences, Inc.
 Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| ILLUMINA, INC. | Biotechnology | Director/Board Member Director/Board Member | |
ARCH Venture Partners LLC
 ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners LLC is a Venture Capital firm founded in 1986. The firm is headquartered in Chicago with additional office in Dublin. | Investment Managers | Private Equity Analyst Private Equity Analyst Private Equity Investor | |
| 4SC AG | Biotechnology | Investor Relations Contact Director/Board Member | |
Foundation for Innovative New Diagnostics
 Foundation for Innovative New Diagnostics Medical/Nursing ServicesHealth Services Foundation for Innovative New Diagnostics provides healthcare services. It enables the development and delivery of much-needed diagnostic tests for poverty-related diseases, including tuberculosis, malaria, HIV/AIDS, sleeping sickness, hepatitis C, leishmaniasis, Chagas disease, Buruli ulcer, febrile illnesses and infectious diseases with outbreak potential, such as Ebola. The company was founded in 2003 and is headquartered in Geneva, Switzerland. | Medical/Nursing Services | Chairman Director/Board Member | |
| VERACYTE, INC. | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member | |
Corbus Pharmaceuticals, Inc.
 Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corbus Pharmaceuticals, Inc. is engaged in biotechnology services. The company is headquartered in Norwood, MA. | Pharmaceuticals: Major | Director/Board Member | |
| AFFIMED N.V. | Biotechnology | Chief Tech/Sci/R&D Officer Public Communications Contact | |
Syntimmune, Inc.
 Syntimmune, Inc. BiotechnologyHealth Technology Syntimmune, Inc. engages in the research and development of therapeutics for autoimmune diseases based on neonatal Fc receptor biology. Its pipeline include SYNT001 which has target indication for dermatology, hematology, and neurology. It also focuses on pre-clinical investigation of SYTN002 and related compounds such as peptide mimetics. The company was founded by Laurence J. Blumberg and Richard S. Blumberg in 2013 and is headquartered in Boston, MA. | Biotechnology | Director/Board Member President | |
| NOVARTIS AG | Pharmaceuticals: Major | Director/Board Member Chairman Chief Tech/Sci/R&D Officer | |
| Stanford University | College/University | Doctorate Degree Undergraduate Degree | |
| MEDIGENE AG | Biotechnology | Director of Finance/CFO Director/Board Member Chief Tech/Sci/R&D Officer | |
| University of Oxford | College/University | Doctorate Degree Doctorate Degree Graduate Degree | |
Roche Diagnostics Corp.
 Roche Diagnostics Corp. Medical SpecialtiesHealth Technology Roche Diagnostics Corp. develops and manufactures diagnostic products. It offers anticoagulation management, blood gas and electrolytes, cholesterol and urinalysis products. The firm provides a broad portfolio of tools that help healthcare providers in the prevention, diagnosis and management of diseases like HPV, HIV, heart failure and diabetes, as well as other medical conditions, such as fertility and blood coagulation. Its products and services uses by researchers, physicians, patients, hospitals and laboratories worldwide. The company was founded in 1964 by Willard Eason and is headquartered in Indianapolis, IN. | Medical Specialties | Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
SHS Gesellschaft für Beteiligungsmanagement mbH
 SHS Gesellschaft für Beteiligungsmanagement mbH Investment ManagersFinance SHS Gesellschaft für Beteiligungsmanagement mbH (SHS) is an independent private equity and venture capital firm founded by Bernhard Schirmers and Reinhilde Spatscheck in 1993, and was headquartered in Tübingen, Baden-Württemberg in the southwest of Germany. | Investment Managers | Private Equity Investor Private Equity Investor | |
| Yale University | College/University | Undergraduate Degree Doctorate Degree Graduate Degree | |
| University of Wisconsin | College/University | Undergraduate Degree Doctorate Degree | |
| University of Kiel | College/University | Doctorate Degree Doctorate Degree | |
| University of Maryland | College/University | Undergraduate Degree Undergraduate Degree | |
Versant Venture Management LLC
 Versant Venture Management LLC Investment ManagersFinance Versant Venture Management LLC (Versant Ventures) is an independent venture capital firm founded in 1999 by Brian Atwood, Samuel Colella, Bill Link and Ross Jaffe. The firm is headquartered in San Francisco with additional offices in Basel and Vancouver. | Investment Managers | Private Equity Investor Private Equity Investor | |
| HEIDELBERG PHARMA AG | Pharmaceuticals: Major | Public Communications Contact Human Resources Officer General Counsel | |
| Georgetown University | College/University | Masters Business Admin Undergraduate Degree | |
| University of Münster | College/University | Undergraduate Degree Doctorate Degree | |
| University of Zurich | College/University | Corporate Officer/Principal Doctorate Degree | |
| Freie Universität Berlin | College/University | Doctorate Degree Graduate Degree | |
| Swiss Federal Institute of Technology | College/University | Graduate Degree Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree | |
| Ludwig-Maximilians-Universität München | College/University | Graduate Degree Doctorate Degree | |
| VIVORYON THERAPEUTICS N.V. | Biotechnology | Director/Board Member Director/Board Member | |
BlackThorn Therapeutics, Inc.
 BlackThorn Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Blackthorn Therapeutics, Inc. manufactures and markets medicines for neuro developmental disorders. The company is headquartered in San Francisco, CA. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| PIERIS PHARMACEUTICALS, INC. | Biotechnology | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| CUREVAC N.V. | Pharmaceuticals: Major | Director/Board Member Investor Relations Contact | |
Monograph Capital Advisors (UK) LLP
 Monograph Capital Advisors (UK) LLP Investment ManagersFinance Monograph Capital Advisors (UK) LLP (Monograph Capital) is a private equity and venture capital firm founded in 2021 by Fred Ehrenkranz Cohen and Charles Conn. The firm is headquartered in London, GB. | Investment Managers | Founder Founder | |
| NEUMORA THERAPEUTICS, INC. | Pharmaceuticals: Major | Founder Founder | |
iOmx Therapeutics AG
 iOmx Therapeutics AG BiotechnologyHealth Technology iOmx Therapeutics AG develops immunotherapy treatments for cancer patients. It specializes in immuno oncology, drug development and cancer therapy. The company was founded by Nisit Khandelwal, Philipp Beckhove, Patrick Baeuerle, Sebastian Meier-Ewert and Elmar Maier in March 2016 and is headquartered in Munich, Germany. | Biotechnology | Chairman Director/Board Member | |
Carrick Therapeutics UK Ltd.
 Carrick Therapeutics UK Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Carrick Therapeutics Ltd., Carrick Therapeutics UK Ltd. is a clinical-stage biopharmaceutical company based in Oxford, UK. Carrick Therapeutics translates in-house and in-licensed assets to target the most aggressive and resistant forms of cancer, working in combination with existing oncology drugs to address unmet patient needs. The British company focuses on developing innovative therapies to improve patient outcomes in oncological therapy. The private company's therapies have potential in advanced breast, prostate, and ovarian cancers, with further potential in pancreatic and Ewing's sarcoma. Timothy R. Pearson has been the CEO of the company since 2019. | Miscellaneous Commercial Services | Chairman |
Statistieken
Internationaal
| Verenigde Staten | 24 |
| Duitsland | 19 |
| Zwitserland | 4 |
| Verenigd Koninkrijk | 4 |
| Nederland | 2 |
Sectoraal
| Health Technology | 29 |
| Consumer Services | 13 |
| Finance | 5 |
| Commercial Services | 3 |
| Health Services | 2 |
Operationeel
| Director/Board Member | 254 |
| Corporate Officer/Principal | 144 |
| Independent Dir/Board Member | 82 |
| Chairman | 73 |
| Chief Executive Officer | 39 |
Sterkste connecties
| Insiders | |
|---|---|
| Fred Cohen | 58 |
| George Golumbeski | 36 |
| Daniel Camus | 31 |
| Gerald Heinz Möller | 29 |
| Karin Eastham | 29 |
| Paul Berns | 28 |
| Wendy Johnson | 23 |
| David Lemus | 22 |
| Frank Morich | 21 |
| Hans Jörg Reinhardt | 20 |
| Sunil Agarwal | 17 |
| Geoffrey Nicholas Vernon | 17 |
| Klaus Kühn | 15 |
| Michael Brosnan | 14 |
| Mark Murcko | 14 |
- Beurs
- Insiders
- Barbara Krebs-Pohl
- Bedrijfsconnecties
